Replies to post #698946 on NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Marzan - Plus we just gained additional KOL and institutional support, as in stamp of approval against conflicted interests, that may consider trying to undermine NWBO with a cadre of bought and paid for researchers.

[dstock07734]

marzan,

Roswell Park Cancer Institute is a world-renowned institution. Being able to connect with an institution like this can bring NWBO under big limelight.

I am not sure about the technology from Roswell Park Cancer Institute. I cannot comment. Dr. Pawel Kalinski had a big funding on immunotherpay. The following is part of the description.

The NCI grant, which involves partners from both UPMC and The Tisch Cancer Institute at Mount Sinai, will enable five new phase II or phase IIA clinical trials to assess the efficacy of this multipronged approach — two studies in patients with metastatic colorectal cancer, one in patients with checkpoint-resistant advanced melanoma and two in advanced ovarian cancer. Three of the five studies will be conducted at Roswell Park, with the two ovarian cancer studies to be led at UPMC’s Hillman Cancer Center, with participation from Roswell Park.

Here is the interesting record history of the trial mentioned in today's PR. Also it will be very interesting to make a comparison in outcome measures between the trial by Roswell Park and our combo trial.

https://clinicaltrials.gov/study/NCT04093323?tab=history&a=33&b=34&compareMode=sideBySide#version-content-panel

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma
https://clinicaltrials.gov/study/NCT04093323#study-plan

Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
https://clinicaltrials.gov/study/NCT04201873#study-plan